HealthMigraine Prevention Drug Receives FDA Approval: Aimovig By Amgen Is The First Of Its Kind Aimovig, designed for long-term migraine prevention, will now go on sale after receiving approval from the U.S. Food and Drug Administration. The drug is the first of its kind, and it could soon mean the end of chronic migraines.by Aaron Mamiit
HealthFDA Approves Lucemyra, The First Non-Opioid Drug For Opioid Withdrawal Symptoms Up To 14 Daysby Steven Lerner
HealthFDA Warns Of EpiPen Shortage: How To Be Prepared When You Need An Emergency Allergy Shotby Alexandra Burlacu
HealthMarijuana-Based Drug For Seizures Gets Unanimous Recommendation From FDA Committeeby Carl Velasco
HealthFDA Issues First Ever Mandatory Recall For Contaminated Food: Kratom Products With Salmonellaby Aaron Mamiit
HealthThe FDA Is Taking Steps To Combat Opioid Addiction, Plans Expanded Access To Medication-Assisted Therapyby Carl Velasco
HealthAntibiotic Clarithromycin Can Potentially Raise Risk Of Death In Patients With Heart Diseaseby Samriddhi Dastidar